Neuraly Raises $36M to Advance Potential Parkinson’s Therapy into Clinical Testing

Neuraly announced it has raised $36 million to advance its lead candidate NLY01 into clinical testing as a potential disease-modifying agent for Parkinson’s disease, and to develop other investigative compounds for this and similar neurodegenerative disorders. The company, a Johns Hopkins University startup, expects to start a clinical trial of NLY01 this year. “Currently, there aren’t

Ni un huracán nos puede parar: La Parkinson’s Foundation presenta su primera conferencia en español en Puerto Rico

Click Here For English Claudia Martínez, MD, la coordinadora de alcance hispano del Muhammad Ali Parkinson Center en Phoenix, AZ, parte del grupo de Centros de Excelencia de Parkinson’s Foundation, no se detuvo a pensar en aceptar la propuesta de ser parte del comité logístico de la primera conferencia de la fundación en el Caribe. Ella

Parkinson’s Foundation Hosts First Parkinson’s Symposium in Puerto Rico

Claudia Martinez, MD, Hispanic Outreach Coordinator at the Muhammad Ali Parkinson Center in Phoenix, AZ, a Parkinson’s Foundation Center of Excellence, did not hesitate when she was asked to join the planning committee for the first Parkinson’s Foundation conference held in the Caribbean. She knew how important this conference would be for the community and

New Chemical Probe May Shed Light on Role of Potential Biomarker in Parkinson’s, Study Suggests

A new chemical probe that binds to a protein called DJ-1 — a sensor of oxidative stress and a potential biomarker of Parkinson’s disease — may help researchers understand how the protein participates in disease progression, a study suggests. The study, “A chemical probe to monitor the parkinsonism- associated protein DJ-1 in live cells,” was published in

Computer Model to Select Parkinson’s Patients Who Benefit Most from Deep Brain Stimulation

Cleveland Clinic researchers have developed a new model that accurately predicts whether quality of life would improve in Parkinson’s disease patients after deep brain stimulation, a new study shows. The tool may help select those who will benefit the most from the procedure, guiding patients and physicians in the decision-making process. The study, “Quality of

The ABCs of Parkinson’s: The Letter D

Fourth in a series. Read part one, two, and three. In this column, the letter D is for dystonia, drooling, and dandelions. Dystonia Dystonia is a neurological movement disorder that causes sustained muscle contractions (ouch!). Twisting and repetitive movements or abnormal postures (more ouch) can be a part of having Parkinson’s disease. Symptoms can include disturbed

Brain Degeneration May Affect Job Choices Before Parkinson’s Diagnosis, Study Suggests

Parkinson’s is less prevalent in individuals with artistic occupations than in those with more conventional jobs, suggesting that brain degeneration may influence job choices even before a Parkinson’s diagnosis, a study shows. Conducted by scientists in the Netherlands, the study, “Professional occupation and the risk of Parkinson Disease,” appeared in the European Journal of Neurology.

Sustained release Exendin-4 Reduces Neurodegeneration in Parkinson’s Rat Model, Study Shows

A new long-lasting formulation of exendin-4, called PT302, reduced neurodegeneration in a rat model of Parkinson’s disease, according to new data from a preclinical study by Peptron. The study, “Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease,” was published in Scientific Reports. Parkinson’s

Nerve Damage in Hearts of Parkinson’s Patients Can Be Monitored with Imaging Tools, Animal Study Reports

Cardiovascular damage in Parkinson’s patients, due to nerve cell loss in the heart, can be captured by imaging stress and inflammation molecules — a process that may help to determine the mechanisms behind such damage and ways of treating neurodegeneration in the heart, researchers report. The study by researchers at the University of Wisconsin-Madison, “In vivo